SK Biopharmaceuticals CEO Lee Dong-hoon speaks at a press event on Monday announcing the joint venture formed between the Korean company and Eurofarma in San Francisco. [SK BIOPHARMACEUTICALS] SAN ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
As global markets continue to react to political developments and economic indicators, major indexes like the S&P 500 have reached new highs amid optimism over potential trade deals and AI investments ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
As global markets navigate through tariff uncertainties and mixed economic indicators, investors are keenly watching for opportunities that arise from these volatile conditions. In such an environment ...
1 Day 326030 0.46% DJIA 0.65% S&P 500 -1.46% Health Care/Life Sciences -0.52% ...
Eighty-four biopharmaceuticals are now in general medical use (see Table 1). Some 60 million patients worldwide thus far have benefited from these drugs, and the industry's global market value ...